Synthesis and cytotoxicity studies of methoxy benzyl substituted titanocenes

Journal of Organometallic Chemistry

Volumn 693, Issue 3, 2008, Pages 526-536

  Claffey, James ^a   Hogan, Megan ^a   Müller Bunz, Helge ^a   Pampillón, Clara ^a   Tacke, Matthias ^a  

^a University College Dublin   (Ireland)

Author keywords

Anti cancer drugs; Cisplatin; Fulvene; Hydridolithiation; LLC PK; RCC; Titanocene

Indexed keywords

CYTOTOXICITY; DENSITY FUNCTIONAL THEORY; SINGLE CRYSTALS; SYNTHESIS (CHEMICAL); TITANIUM; X RAY DIFFRACTION ANALYSIS;

CISPLATIN; HYDRIDOLITHIATION; TITANOCENE;

LITHIUM COMPOUNDS;

SUIDAE;

EID: 38049050226     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2007.11.037     Document Type: Article

References (37)

1. Schilling T., Keppler B.K., Heim M.E., Niebch G., Dietzfelbinger H., Rastetter J., and Hanauske A.R. Invest. New Drugs 13 (1996) 327-332
2. Melendez E. Crit. Rev. Oncol./Hematol. 42 (2002) 309-315
3. Caruso F., and Rossi M. Metal Ions Biol. Syst. 42 (2004) 353-384
4. Lummen G., Sperling H., Luboldt H., Otto T., and Rubben H. Cancer Chemother. Pharmacol. 42 (1998) 415-417
5. Kröger N., Kleeberg U.R., Mross K., Edler L., Saß G., and Hossfeld D. Onkologie 23 (2000) 60-62
6. Allen O.R., Croll L., Gott A.L., Knox R.J., and McGowan P.C. Organometallics 23 (2004) 288-292
7. Causey P., and Baird M. Organometallics 23 (2004) 4486-4494
8. Meyer R., Brink S., van Rensburg C., Jooné G., Görls H., and Lotz S. J. Organomet. Chem. 690 (2005) 117-125
9. Fox S., Dunne J.P., Tacke M., and Gallagher J.F. Inorg. Chim. Acta 357 (2004) 225-234
10. Tacke M., Cuffe L.P., Gallagher W.M., Lou Y., Mendoza O., Müller-Bunz H., Rehmann F.-J.K., and Sweeney N. J. Organomet. Chem. 689 (2004) 2242-2249
11. Tacke M., Cuffe L.P., Gallagher W.M., Lou Y., Mendoza O., Müller-Bunz H., Rehmann F.-J.K., and Sweeney N. J. Inorg. Biochem. 98 (2004) 1987-1994
12. Rehmann F.-J.K., Rous A.J., Mendoza O., Sweeney N.J., Strohfeldt K., Gallagher W.M., and Tacke M. Polyhedron 24 (2005) 1250-1255
13. Rehmann F.-J.K., Cuffe L.P., Mendoza O., Rai D.K., Sweeney N., Strohfeldt K., Gallagher W.M., and Tacke M. Appl. Organomet. Chem. 19 (2005) 293-300
14. Sweeney N.J., Mendoza O., Müller-Bunz H., Pampillón C., Rehmann F.-J.K., Strohfeldt K., and Tacke M. J. Organometal. Chem. 690 (2005) 4537-4544
15. Sweeney N.J., Gallagher W.M., Müller-Bunz H., Pampillón C., Strohfeldt K., and Tacke M. J. Inorg. Biochem. 100 (2006) 1479-1486
16. Strohfeldt K., Müller-Bunz H., Pampillón C., Sweeney N.J., and Tacke M. Eur. J. Inorg. Chem. (2006) 4621-4628
17. Sweeney N.J., Claffey J., Müller-Bunz H., Pampillón C., Strohfeldt K., and Tacke M. Appl. Organometal. Chem. 21 (2007) 57-65
18. Pampillón C., Sweeney N., Strohfeldt K., and Tacke M. Inorg. Chim. Acta 359 (2006) 3969-3975
19. Pampillón C., Mendoza O., Sweeney N., Strohfeldt K., and Tacke M. Polyhedron 25 (2006) 2101-2108
20. Pampillón C., Sweeney N.J., Strohfeldt K., and Tacke M. J. Organomet. Chem. 692 (2007) 2153-2159
21. Pampillón C., Claffey J., Hogan M., and Tacke M. Z. Allg. Anorg. Chem. 633 (2007) 1695-1700
22. Pampillón C., Claffey J., Hogan M., Strohfeldt K., and Tacke M. Trans. Met. Chem. 32 (2007) 434-441
23. Hogan M., Claffey J., Pampillón C., Watson R.W.G., and Tacke M. Organometallics 26 (2007) 2501-2506
24. Hickey T., Claffey J., Fitzpatrick E., Hogan M., Pampillón C., and Tacke M. Invest. New Drugs 25 (2007) 425-433
25. C. Pampillón, J. Claffey, M. Hogan, M. Tacke, BioMetals (2007). http://dx.doi.org/10.1007/s10534-007-9108-5.
26. C. Pampillón, J. Claffey, K. Strohfeldt, M. Tacke, Eur. J. Med. Chem. (2007)http://dx.doi.org/10.1016/j.ejmech.2007.02.011.
27. Kelter G., Sweeney N.J., Strohfeldt K., Fiebig H.-H., and Tacke M. Anti-Cancer Drugs 16 (2005) 1091-1098
28. Oberschmidt O., Hanauske A.R., Rehmann F.-J.K., Strohfeldt K., Sweeney N.J., and Tacke M. Anti-Cancer Drugs 16 (2005) 1071-1073
29. Oberschmidt O., Hanauske A.R., Pampillón C., Sweeney N.J., Strohfeldt K., and Tacke M. Anti-Cancer Drugs 18 (2007) 317-321
30. O'Connor K., Gill C., Tacke M., Rehmann F.-J.K., Strohfeldt K., Sweeney N., Fitzpatrick J.M., and Watson R.W.G. Apoptosis 11 (2006) 1205-1214
31. Valaderes M.C., Ramos A.L., Rehmann F.-J.K., Sweeney N.J., Strohfeldt K., Tacke M., and Queiroz M.L.S. Eur. J. Pharmacol. 534 (2006) 264-270
32. Fichtner I., Pampillón C., Sweeney N.J., Strohfeldt K., and Tacke M. Anti-Cancer Drugs 17 (2006) 333-336
33. Beckhove P., Oberschmidt O., Hanauske A.R., Pampillón C., Schirrmacher V., Sweeney N.J., Strohfeldt K., and Tacke M. Anti-Cancer Drugs 18 (2007) 311-315
34. gaussian 03 (Revision C.02), Gaussian Inc., Wallingford CT 497, 2005.
35. G.M. Sheldrick, sadabs Version 2.03, University of Göttingen, Germany, 2002.
36. G.M. Sheldrick, shelxs-97 and shelxl-97, University of Göttingen, Germany, 1997.
37. Stone K.J., and Little R.D. J. Org. Chem. 49 (1984) 1849-1853